Notice2021-21807
Lead Exposure and Prevention Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 6, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Lead Exposure and Prevention Advisory Committee (LEPAC). This meeting is open to the public by teleconference but advance registration by November 19, 2021 is needed to receive the information to join the meeting. The registration link is https://www.zoomgov.com/webinar/register/WN_qeMSB7npRJ23PTV6t1KMtQ.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 191 (Wednesday, October 6, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 191 (Wednesday, October 6, 2021)]
[Notices]
[Page 55616]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-21807]
[[Page 55616]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This meeting is open to the public by
teleconference but advance registration by November 19, 2021 is needed
to receive the information to join the meeting. The registration link
is <a href="https://www.zoomgov.com/webinar/register/WN_qeMSB7npRJ23PTV6t1KMtQ">https://www.zoomgov.com/webinar/register/WN_qeMSB7npRJ23PTV6t1KMtQ</a>.
DATES: The meeting will be held on December 3, 2021, from 9:00 a.m. to
4:15 p.m., EST.
ADDRESSES: Register in advance at <a href="https://www.zoomgov.com/webinar/register/WN_qeMSB7npRJ23PTV6t1KMtQ">https://www.zoomgov.com/webinar/register/WN_qeMSB7npRJ23PTV6t1KMtQ</a> to receive the information to join
the meeting.
FOR FURTHER INFORMATION CONTACT: Alexis Pullia, M.P.H., C.P.H.,
Committee Management Specialist, National Center for Environmental
Health, CDC, 4770 Buford Highway, Atlanta, GA, 30341, Telephone: (770)
488-3300; Email: <a href="/cdn-cgi/l/email-protection#c9a5acb9a8aa89aaadaae7aea6bf"><span class="__cf_email__" data-cfemail="117d74617072517275723f767e67">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27,
Registry for Lead Exposure and Advisory Committee. The Secretary,
Department of Health and Human Services (HHS) and by delegation, the
Director, CDC and Administrator, NCEH/ATSDR, are authorized under
Section 2203 of Public Law 114-322 (42 U.S.C. 300j-27) to review
research and Federal programs and services related to lead poisoning
and to identify effective services and best practices for addressing
and preventing lead exposure in communities.
The LEPAC is charged with providing advice and guidance to the
Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on (1)
reviewing Federal programs and services available to individual
communities exposed to lead; (2) reviewing current research on lead
exposure to identify additional research needs; (3) reviewing and
identifying best practices, or the need for best practices regarding
lead screening and the prevention of lead poisoning; (4) identifying
effective services, including services relating to healthcare,
education, and nutrition for individuals and communities affected by
lead exposure and lead poisoning, including in consultation with, as
appropriate, the lead exposure registry as established in Section 2203
(b) of Public Law 114-322; and (5) undertaking any other review or
activities that the Secretary determines to be appropriate.
Matters To Be Considered: The agenda will include updates on the
blood lead reference value, lead-related activities from Federal LEPAC
Members, the 1988 CLIA Amendment, and from Federal environmental
justice efforts focused on lead, a discussion of best practices for
increasing and enhancing screening in underserved populations, and
presentations on mapping efforts to identify populations at higher risk
of lead exposure and Lead Safe Cleveland. Agenda items are subject to
change as priorities dictate.
Public Participation
Procedure for Oral Public Comment: The public comment period is
scheduled on December 3, 2021 from 11:05 a.m. until 11:20 a.m.
Individuals wishing to make a comment during the public comment period,
please email your name, organization, and telephone number by November
19, 2021, to <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4f030a1f0e0c0f2c2b2c61282039">[email protected]</a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-21807 Filed 10-5-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 6, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.